TRUFFTRUFFOTC

Overview Intelligence Charts News Fundamentals Key Metrics Financials Growth Insiders

Latest News

newsfilecorp.com

Red Light Holland Reports Third Quarter 2026 Results and Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - March 3, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based organization advancing a focused strategy within the legal psychedelic sector, centered on consensual data collection and research and development ("R&D") initiatives designed to expand naturally occurring drug development, understanding of psilocybin use and consumer experiences, which in parallel, operates commercial activities across Europe and North America, including psilocybin truffle sales in the Netherlands' legal market and mushroom home grow kits offered through business-to-business ("B2B") and direct-to-consumer ("DTC") channels, in compliance with applicable laws, announces its financial and operational results for the three and nine months ended December 31, 2025 ("Q3 2026"). All figures are reported in Canadian dollars.

newsfilecorp.com

Red Light Holland Reports Second Quarter 2026 Results and Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - December 1, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announces its financial and operational results for the three and six months ended September 30, 2025. All figures are reported in Canadian dollars.

newsfilecorp.com

Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives Second, Larger 5kg Psilocybin Shipment via USA Controlled Substances Import Permit

Toronto, Ontario--(Newsfile Corp. - November 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws is excited to announce that it has, for a second time, successfully shipped the Company's naturally occurring psilocybin from their facility in the Netherlands to their research and development partner, Irvine Labs Inc. ("Irvine Labs"), an FDA-compliant and DEA-registered facility in California, United States. With the DEA quota secured and United States Controlled Substances import permit approved, Irvine Labs has now successfully received Red Light Holland's second larger shipment consisting of 5kg of natural psilocybin products, grown in the company's facility in the Netherlands.

newsfilecorp.com

Red Light Holland's Wholly Owned Subsidiary Happy Caps Expands Safeway Partnership to 123 Stores Across the U.S. Pacific Northwest, in Time for American Thanksgiving

Toronto, Ontario--(Newsfile Corp. - November 11, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, is pleased to announce a major U.S. retail expansion milestone for its wholly owned subsidiary, 4316747 Nova Scotia Limited o/a Happy Caps Mushroom Farm ("Happy Caps") with Albertsons Companies and its Safeway banner. Following its successful initial launch in 66 Safeway stores earlier this year, Happy Caps is thrilled to announce an expanded partnership with Albertsons Companies, increasing distribution by 86% to 123 Safeway locations across Oregon and Washington State.

newsfilecorp.com

Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs

Red Light Holland granted Second DEA Import Permit through Irvine Labs for expanded psilocybin research program This United States Controlled Substances Permit, authorizes a significantly larger shipment of psilocybin truffles, from Red Light Holland's Netherlands facility, for continued R&D Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announced today that its research and development partner, Irvine Labs Inc., California, USA, has received a second United States Controlled Substances import permit. This latest import permit authorizes a significantly larger shipment of psilocybin truffles for continued research and development activities by their FDA-Compliant, DEA-Registered Lab partner.

newsfilecorp.com

Red Light Holland Receives Official Psilocybin COA Through FDA-Compliant, DEA-Registered Partner, Irvine Labs, USA

Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announced today that it has received an official Certificate of Analysis (COA) through its research and development partner, Irvine Labs Inc., California, USA, confirming psilocybin potency and process validation for potential medical grade manufacturing applications. The testing was conducted on Red Light Holland's naturally derived psilocybin truffles from its Netherlands facility, which were successfully shipped to the FDA-compliant and DEA-registered Irvine Labs facility in California, USA.

newsfilecorp.com

Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Continued Safeway Partnership to 123 Stores Across Two Seasonal Programs in the U.S.

Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, is pleased to announce its secured an expansion milestone for its wholly owned subsidiary, 4316747 Nova Scotia Limited o/a Happy Caps Mushroom Farms ("Happy Caps") with Albertsons Companies and it's Safeway banner. Following its initial mushroom home grow kits U.S. retail launch in 66 Safeway stores, Happy Caps has now secured an additional program with Albertsons Companies and its Safeway banner, increasing its store count by 86% to 123 locations across Oregon and Washington State.

newsfilecorp.com

Red Light Holland Reports First Quarter 2026 Results

Toronto, Ontario--(Newsfile Corp. - August 28, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announces its financial and operational results for the three months ended June 30, 2025, the highlights of which are included in this news release. All figures are reported in Canadian dollars.

newsfilecorp.com

Red Light Holland Updates Bitcoin Balance Sheet Strategy

Purchases of iShares Bitcoin ETF (IBIT) and Progress Toward Arch Public Integration Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, today announced an update on its Bitcoin balance sheet strategy. As part of its previously disclosed plan to allocate up to C$2 million toward Bitcoin and related assets, the Company has continued its disciplined accumulation strategy.

newsfilecorp.com

Red Light Holland Applauds HHS Review of Psilocybin Rescheduling Petition, Expresses Optimism for Reversal of Schedule I Classification

Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of magic truffles to the legal, recreational market within the Netherlands, today welcomes the U.S. Drug Enforcement Administration's (DEA) decision to forward a psilocybin rescheduling petition to the Department of Health and Human Services (HHS) for medical and scientific review. This marks the first time the DEA has advanced such a petition for psilocybin's rescheduling from Schedule I to Schedule II.

newsfilecorp.com

Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs

Initial testing results confirm psilocybin potency and process validation for potential medical grade manufacturing applications Irvine Labs progresses development of proprietary dehydration and packaging processes while preparing for next scheduled import Toronto, Ontario--(Newsfile Corp. - August 18, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws, is pleased to announce that it has received initial testing results from its research and development partner, Irvine Labs Inc. ("Irvine Labs"), confirming the psilocybin quantity and process compatibility from the Company's naturally occurring psilocybin products for potential medical grade manufacturing applications. Following the successful delivery of the first global shipment of psilocybin from Red Light Holland's Netherlands facility to the FDA-compliant and DEA-registered Irvine Labs facility in California in July, initial potency testing via third-party laboratory has now been completed.

newsfilecorp.com

Red Light Holland CEO Todd Shapiro Invited by Blockchain Futurist Conference for Fireside Chat and Panel Hosting

Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws, is pleased to announce that its CEO, Todd Shapiro, has been invited to participate in the Blockchain Futurist Conference in Miami, Florida, from November 5-6, 2025. Mr. Shapiro will engage in a fireside chat and host a panel discussion, highlighting the intersection of blockchain technology, cryptocurrency, and emerging industries like psychedelics.

newsfilecorp.com

Red Light Holland Reports 2025 Audited Year-End Results - Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion

Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, is pleased to report its Audited Annual Consolidated Financial Statements and Management's Discussion & Analysis ("MD&A") for the fiscal years ended March 31, 2025 and 2024. The full set of audited financials and MD&A can be accessed on the Company's website at www.RedLight.co and on SEDAR+ at www.sedarplus.ca.

newsfilecorp.com

Red Light Holland Provides Timing for 2025 Audited Year-End Results and Announces Live Q&A

Red Light Holland will release its 2025 audited year-end results, prior to the opening of the financial markets on Tuesday, July 29th, 2025 CEO Todd Shapiro and CFO Keith Li of Red Light Holland will conduct a live Q&A at 11am on Wednesday, July 30th, 2025. Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, is pleased to announce that it will release its audited financial and operational results for the year-end March 31, 2025, prior to the opening of the financial markets, tomorrow, Tuesday July 29th, 2025.

newsfilecorp.com

Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker

Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws today announced its selection of Arch Public Inc. as a key partner for executing Bitcoin purchases. This decision follows the Company's recent Bitcoin balance sheet strategy announcement on July 15, 2025, and comes on the recommendation of Lead Cryptocurrency Advisor Scott Melker.

newsfilecorp.com

Red Light Holland Announces Bitcoin Balance Sheet Strategy and Names Scott Melker as Lead Cryptocurrency Advisor

Toronto, Ontario--(Newsfile Corp. - July 15, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws proudly announces its Bitcoin Balance Sheet Strategy, led by cryptocurrency titan Scott Melker, "The Wolf of All Streets". This bold initiative aligns the Company's commitment to decentralization and deregulation with the progressive, freedom-driven spirit of psilocybin users and Bitcoin advocates, cementing Red Light Holland as a pioneer in the psychedelics industry.

newsfilecorp.com

Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company's Netherlands Facility via USA Controlled Substances Permit

Groundbreaking and major precedent setting milestone as first global shipment, via USA Controlled Substances import permit, of naturally occurring Psilocybin from Red Light Holland's facility in Europe successfully delivered to the Company's Partner FDA-Compliant and DEA-Registered Irvine Labs in California Psilocybin potency testing and implementation of advanced shelf life extension protocols are immediately underway Red Light Holland and Irvine Labs combined goal is to develop a commercialized and standardized psilocybin product that can be legally sold to emerging markets and used in government-funded pilot programs and clinical trials within the United States Toronto, Ontario--(Newsfile Corp. - July 14, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws is excited to announce that it has successfully shipped the Company's naturally occurring psilocybin from their facility in the Netherlands to their research and development partner, Irvine Labs Inc. ("Irvine Labs"), an FDA-compliant and DEA-registered facility in California, United States. With the DEA quota secured and United States Controlled Substances import permit approved, Irvine Labs has now successfully received Red Light Holland's natural psilocybin products, grown in the company's facility in the Netherlands.

newsfilecorp.com

Red Light Holland Announces Dr. Robin Carhart-Harris as Scientific Advisor

Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, is pleased to announce that Dr. Robin Carhart-Harris, a leading authority in psychedelic research, has joined the Company as an independent Scientific Advisor. Dr. Carhart-Harris will provide strategic guidance on psilocybin research developments and assist with potential academic and regulatory collaborations.

newsfilecorp.com

Red Light Holland Partners with Arizona State University to Support Groundbreaking Psychedelic Genome Project (PGP) Research Study

Toronto, Ontario--(Newsfile Corp. - June 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable law, is pleased to announce its partnership with Arizona State University to support Dr. Candace Lewis, PhD's research study titled "Psychedelic Genome Project – Genomic regulators of psilocybin response." This groundbreaking research aims to advance understanding of the effects of psilocybin on genetic expression and improve nutrition-driven health outcomes.

newsfilecorp.com

Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles

Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the Company's farm in The Netherlands to the United States, via a Controlled Substances Import Permit. Following this major milestone approval, Red Light Holland will ship their carefully packaged raw psilocybin truffles to California based, Irvine Labs, for development of extended shelf-life microdosing capsules.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance